Last updated: 2026-09-16 09:45:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
eXoZymes Inc. (EXOZ) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $6.50, with a market capitalisation of $58.29M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.35 to $18.40. This page covers its latest market performance, valuation, price trends and company information.
$58.29M | |
$6.25 | |
$23.99 | |
$4.35 | |
$6.28 | |
11.12K | |
9.15K | |
-- | |
$18.40 | |
$4.35 | |
-- | |
-- |
eXoZymes Inc. (EXOZ) is trading at $5.99 in pre-market trading as of 2026-09-15 20:11:00, down 4.62% ($0.29) from the previous close of $6.28
Pre-market trading shows how investors are pricing EXOZ before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, eXoZymes Inc. (EXOZ) moved from $6.85 to $6.50, representing a decline of 5.15% ($0.35).
The stock traded between $6.00 and $7.25 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 8.29 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 15.3%
EXOZ is currently trading at $6.50, placing it 15.3% of the way from its 52-week low of $4.35 to its 52-week high of $18.40. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods. The company believes its platform will enable scalable production of chemical molecules found in nature in a process that is alternative to and more environmentally friendly and sustainable than the typical methods used today, such as chemical synthesis, natural extraction, and synthetic biology.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 32 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of eXoZymes Inc. (EXOZ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.